-
A recent deal between the biopharmaceutical companies GlaxoSmithKline and Novartis may mean more jobs and more attention for the Research Triangle. Plus,…
-
Big changes and asset swaps in the pharmaceutical world are happening this week, but the Triangle should be spared of any fall-out.One of the big moves in…
-
Earlier this month, the Food and Drug Administration approved a class of drugs that can cure most hepatitis C infections. That's great news for the more than 3 million Americans infected. But the high cost — $84,000 per course of treatment — means some patients could miss out.
-
North Carolina State University recently beefed up its toxicology database, which could help revolutionize pharmaceutical research.NC State's Comparitive…
-
North Carolina has reduced its rate of antipsychotic drug use in nursing homes by 23 percent over the last year-- that's the highest such improvement rate…
-
The largest drugstore chain in the United States is buying out North Carolina-based Kerr Drug.The banner on the Kerr Drug website says it’s North…
-
The Durham-based pharmaceutical company Quintiles is acquiring a Triangle research organization. Quintiles announced Wednesday it reached a deal with…
-
GlaxoSmithKline hosted a gathering today in RTP for policy, non-profit and business leaders in the biopharmaceutical industry.Jack Bailey, a Senior Vice…
-
Authorities in China say a number of senior executives working for GlaxoSmithKline in that country have been placed under criminal investigation for…
-
Trading on the New York Stock Exchange begins Thursday for North Carolina-based Quintiles.The company announced late Wednesday that it is selling about…